glp 1 is retatrutide Diagram showing the mechanism of action of Retatrutide vs Semaglutide and Tirzepatide:

Semaglutide, a leading GLP-1 receptor agonist, demonstrated a mean weight loss of 14.9% at weekly doses of 2.4 mg, compared with only 2.4% for placebo

Because it is soft, simple, and easy to portion, it's a great option if you struggle with heavier, dense treats or simply want a smaller snack before a meal

But some, like Wegovy, can help treat obesity, too, by slowing your digestion and curbing food cravings

According to the MHRA-approved Summary of Product Characteristics (SmPC), Rybelsus should be taken first thing in the morning, with no more than 120ml of plain water, at least 30 minutes before any food, drink, or other oral medications